Sharyn D Baker - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Sharyn D Baker

Showing results (161-170 of 166) with videos related to

Pageof 17

Sort By:

You have reached the last page of results.This site can display upto 166 results.

Nature Communications|January 18, 2019

Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanismsHaijiao Zhang, Samantha Savage, Anna Reister Schultz, et al.

Blood Cancer Discovery|November 15, 2021

Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic IndicatorsMaarten Fornerod, Jing Ma, Sanne Noort, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 26, 2021

Targeting OCT3 attenuates doxorubicin-induced cardiac injuryKevin M Huang, Megan Zavorka Thomas, Tarek Magdy, et al.

JCI Insight|April 22, 2024

Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemiaOla A Elgamal, Sydney Fobare, Sandip Vibhute, et al.

Blood Neoplasia|April 20, 2026

Results of a phase 1 trial testing ruxolitinib plus venetoclax in patients with relapsed/refractory acute myeloid leukemiaUma Borate, Cristina E Tognon, Yazan F Madanat, et al.

The Journal of Clinical Investigation|March 20, 2025

TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environmentPu Zhang, Ethan C Whipp, Sarah J Skuli, et al.

Pageof 17

Search research articles

Showing results (161-170 of 166) with videos related to

Sort By:

Pageof 17

You have reached the last page of results.This site can display upto 166 results.

Nature Communications|January 18, 2019

Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanismsHaijiao Zhang, Samantha Savage, Anna Reister Schultz, et al.

Blood Cancer Discovery|November 15, 2021

Integrative Genomic Analysis of Pediatric Myeloid-Related Acute Leukemias Identifies Novel Subtypes and Prognostic IndicatorsMaarten Fornerod, Jing Ma, Sanne Noort, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 26, 2021

Targeting OCT3 attenuates doxorubicin-induced cardiac injuryKevin M Huang, Megan Zavorka Thomas, Tarek Magdy, et al.

JCI Insight|April 22, 2024

Pyrimidine depletion enhances targeted and immune therapy combinations in acute myeloid leukemiaOla A Elgamal, Sydney Fobare, Sandip Vibhute, et al.

Blood Neoplasia|April 20, 2026

Results of a phase 1 trial testing ruxolitinib plus venetoclax in patients with relapsed/refractory acute myeloid leukemiaUma Borate, Cristina E Tognon, Yazan F Madanat, et al.

The Journal of Clinical Investigation|March 20, 2025

TP53 mutations and TET2 deficiency cooperate to drive leukemogenesis and establish an immunosuppressive environmentPu Zhang, Ethan C Whipp, Sarah J Skuli, et al.

Pageof 17